CPNE6 (Gene)

Synonyms:CPNE6, ENTREZ:9362, HGNC:2319, MIM:605688, NM_001280558, NM_001385056, NM_001385057, NM_001385058, NM_006032, NP_001267487, NP_001371985, NP_001371986, NP_001371987, NP_006023, NR_169564, XM_005268217, XM_024449744, XM_024449745, XM_024449747, XM_024449748, XM_024449749, XP_005268274, XP_024305512, XP_024305513, XP_024305515, XP_024305516, XP_024305517, copine 6
Omim:OMIM:605688
Id:ENSG00000100884
Hgnc:HGNC:2319
Entrez:9362
Description:copine 6
This gene encodes a member of the copine family. Members of this family are calcium-dependent, phospholipid-binding proteins with C2 domains, two calcium- and phospholipid-binding domains. Through their domain structure and lipid binding capabilities, these proteins may play a role in membrane trafficking. This protein is thought to be brain-specific and has a domain structure of two N-terminal C2 domains and one von Willebrand factor A domain. It may have a role in synaptic plasticity. [provided by RefSeq, Jul 2013]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CPNE6's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CPNE6.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CPNE6.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CPNE6.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CPNE6.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.